JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265135

Human SUGP2 (SFRS14) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SUGP2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 459 bp deletion in exon 3.

View Alternative Names

Arginine/serine-rich-splicing factor 14, DKFZp779L2418, KIAA0365, SUGP2_HUMAN, SURP and G-patch domain-containing protein 2, Splicing factor, Splicing factor, arginine/serine-rich 14, arginine/serine-rich 14

1 Images
Sanger Sequencing - Human SUGP2 (SFRS14) knockout HeLa cell line (AB265135)
  • Sanger seq

Unknown

Sanger Sequencing - Human SUGP2 (SFRS14) knockout HeLa cell line (AB265135)

Homozygous : 459 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 459 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265135-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265135 Human SUGP2 (SFRS14) knockout HeLa cell line", "number":"AB265135-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265135-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265135 Human SUGP2 (SFRS14) knockout HeLa cell line", "number":"AB265135-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SUGP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SFRS14 also known as SUGP2 is a protein involved in RNA splicing processes. It facilitates the assembly of spliceosomal complexes which are important in removing introns from pre-mRNA transcripts. The molecular mass of SFRS14 is approximately 111 kDa. This protein expresses widely in human tissues with significant expression in the brain heart and reproductive tissues. Its function in these tissues indicates it plays an important role in post-transcriptional gene regulation.
Biological function summary

SFRS14 influences the regulation of alternative splicing by interacting with other splicing factors. It acts as part of the spliceosome complex which is responsible for the precise cutting and joining of exons from mRNA precursors. SFRS14 ensures the correct splicing of transcripts related to various cellular functions. Its role in alternative splicing helps generate protein diversity which is essential in maintaining cellular processes and adaptation to different physiological conditions.

Pathways

This protein takes part in the mRNA processing pathway and the gene expression pathway. In the mRNA processing pathway SFRS14 assists in accurately assembling the spliceosome ensuring proper splicing of precursor mRNA. Relating to other proteins in these pathways SFRS14 interacts with members of the SR protein family which includes proteins like SFRS1 and SFRS2. These interactions highlight its contribution to the regulation of gene expression through mRNA maturation.

Several cases relate improper function of SFRS14 to specific pathologies like cancer and neurological conditions. In cancer aberrant alternative splicing events which involve SFRS14 alter the expression of genes that control cell growth and apoptosis. The SFRS14 protein connects to the BCL2 family of proteins which play a role in apoptotic processes in cancer cells. Similarly disruptions in SFRS14 function have been observed in neurodegenerative diseases where it may affect neuronal survival and plasticity due to faulty splicing of essential neuronal transcripts.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com